Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Troussard

Showing results (21-30 of 155) with videos related to

Pageof 16
Sort By:
Bulletin Du Cancer|May 23, 2021
[Hairy cell leukemia: What are the best treatment options for relapsed or refractory patients?]Xavier Troussard, Elsa Maitre, Jérôme Paillassa
Current Oncology Reports|April 11, 2022
Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic AdvancesJérôme Paillassa, Elsa Maitre, Xavier Troussard
Journal of Cellular and Molecular Medicine|August 2, 2023
Hairy cell leukaemia with unusual BRAF mutationsElsa Maitre, Margaret Macro, Xavier Troussard
American Journal of Hematology|October 28, 2021
Hairy cell leukemia 2022: Update on diagnosis, risk-stratification, and treatmentXavier Troussard, Elsa Maître, Edouard Cornet
Current Opinion in Oncology|July 9, 2015
New insights in the management of patients with hairy cell leukemiaEdouard Cornet, Gandhi Damaj, Xavier Troussard
American Journal of Hematology|October 9, 2019
Hairy cell leukemia: 2020 update on diagnosis, risk stratification, and treatmentElsa Maitre, Edouard Cornet, Xavier Troussard
International Journal of Cancer|February 3, 2005
The enigmatic role of cyclin D1 in multiple myelomaDenis Lesage, Xavier Troussard, Brigitte Sola
American Journal of Hematology|March 5, 2024
Hairy cell leukemia 2024: Update on diagnosis, risk-stratification, and treatment-Annual updates in hematological malignanciesXavier Troussard, Elsa Maître, Jérôme Paillassa
Therapeutic Advances in Hematology|April 22, 2022
Updates in hairy cell leukemia (HCL) and variant-type HCL (HCL-V): rationale for targeted treatments with a focus on ibrutinibJérôme Paillassa, Firas Safa, Xavier Troussard
Frontiers in Oncology|January 9, 2023
Novel targeted treatments in hairy cell leukemia and other hairy cell-like disordersElsa Maitre, Jerome Paillassa, Xavier Troussard
Pageof 16

Showing results (21-30 of 155) with videos related to

Sort By:
Pageof 16
Bulletin Du Cancer|May 23, 2021
[Hairy cell leukemia: What are the best treatment options for relapsed or refractory patients?]Xavier Troussard, Elsa Maitre, Jérôme Paillassa
Current Oncology Reports|April 11, 2022
Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic AdvancesJérôme Paillassa, Elsa Maitre, Xavier Troussard
Journal of Cellular and Molecular Medicine|August 2, 2023
Hairy cell leukaemia with unusual BRAF mutationsElsa Maitre, Margaret Macro, Xavier Troussard
American Journal of Hematology|October 28, 2021
Hairy cell leukemia 2022: Update on diagnosis, risk-stratification, and treatmentXavier Troussard, Elsa Maître, Edouard Cornet
Current Opinion in Oncology|July 9, 2015
New insights in the management of patients with hairy cell leukemiaEdouard Cornet, Gandhi Damaj, Xavier Troussard
American Journal of Hematology|October 9, 2019
Hairy cell leukemia: 2020 update on diagnosis, risk stratification, and treatmentElsa Maitre, Edouard Cornet, Xavier Troussard
International Journal of Cancer|February 3, 2005
The enigmatic role of cyclin D1 in multiple myelomaDenis Lesage, Xavier Troussard, Brigitte Sola
American Journal of Hematology|March 5, 2024
Hairy cell leukemia 2024: Update on diagnosis, risk-stratification, and treatment-Annual updates in hematological malignanciesXavier Troussard, Elsa Maître, Jérôme Paillassa
Therapeutic Advances in Hematology|April 22, 2022
Updates in hairy cell leukemia (HCL) and variant-type HCL (HCL-V): rationale for targeted treatments with a focus on ibrutinibJérôme Paillassa, Firas Safa, Xavier Troussard
Frontiers in Oncology|January 9, 2023
Novel targeted treatments in hairy cell leukemia and other hairy cell-like disordersElsa Maitre, Jerome Paillassa, Xavier Troussard
Pageof 16